As part of our ongoing series focussing on available medicines in Australia, we have added a product review of Enzalutamide in adult patients with metastatic or non-metastatic castration-resistant prostate cancer.
This review discusses pharmacological properties, mechanism of action, drug interactions and major studies featuring Enzalutamide. It also provides commentary and recommendations from Dr Laurence Krieger, Consultant General Physician and undergraduate trainee supervisor for the Royal College of Physicians at Royal North Shore Hospital, Sydney.
Please login below to download this issue (PDF)